<SEC-DOCUMENT>0001169245-21-000031-index.html : 20210429 <SEC-HEADER>0001169245-21-000031.hdr.sgml : 20210429 <ACCEPTANCE-DATETIME>20210428200903 ACCESSION NUMBER: 0001169245-21-000031 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20210428 FILED AS OF DATE: 20210429 DATE AS OF CHANGE: 20210428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38697 FILM NUMBER: 21866523 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 </SEC-HEADER> <DOCUMENT> <TYPE>DEF 14A <SEQUENCE>1 <FILENAME>proxy2021.htm <DESCRIPTION>DEF 14A <TEXT> Document 1 - file: proxy2021.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>phasebio2020logo1.jpg <TEXT> Document 2 - file: phasebio2020logo1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>phasebio2020proxystat_imag.gif <TEXT> Document 3 - file: phasebio2020proxystat_imag.gif
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>phasebiopcdraftv2_pagex11.jpg <TEXT> Document 4 - file: phasebiopcdraftv2_pagex11.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>phasebiopcdraftv2_pagex21.jpg <TEXT> Document 5 - file: phasebiopcdraftv2_pagex21.jpg
</DOCUMENT> </SEC-DOCUMENT>